logo
Empatica Achieves CE MDR Certification for EpiMonitor, Bringing Round-the-Clock Epilepsy Monitoring to Europe

Empatica Achieves CE MDR Certification for EpiMonitor, Bringing Round-the-Clock Epilepsy Monitoring to Europe

Yahoo28-05-2025
BOSTON, May 28, 2025--(BUSINESS WIRE)--Following its successful US launch and FDA clearance, Empatica is proud to announce that EpiMonitor, its pioneering epilepsy monitoring solution, is now a CE-certified device according to EU Medical Device Regulation 2017/745 and available in Europe. EpiMonitor is a game-changing, medical-grade wearable and app combination that revolutionizes epilepsy care, providing seizure detection and alerting alongside continuous health monitoring capabilities also used in clinical research settings.
EpiMonitor comprises the sophisticated EmbracePlus watch and a companion smartphone app. EpiMonitor's algorithm continuously analyzes user data, looking for patterns that may resemble a generalized tonic-clonic seizure, and sends automated alerts to caregivers with scientifically proven 98% accuracy. EpiMonitor also offers a detailed sleep, activity, and seizure diary, providing people with epilepsy and their doctors with important information to make empowered decisions on their health journey.
EpiMonitor is now available in Germany, France, Italy, Spain, Denmark, Sweden, Belgium, Luxembourg, Austria, Liechtenstein, Ireland, the Netherlands, Malta, and Finland. The EpiMonitor app is also available in all local languages for a seamless experience for its users.
"EpiMonitor's availability in Europe is a great milestone for the epilepsy community," said Simone Tognetti, Empatica's CTO & Co-founder. "Our goal is to continue bringing technology that improves lives to more people around the world. EpiMonitor is the world's only non-invasive, medical-grade wearable for night and day epilepsy monitoring, and our rigorous engineering methods and quality processes guarantee unmatched safety and accuracy. With EpiMonitor, we have taken the best of our previous wearables and amplified it in a solution that uses our most innovative and powerful technology, alongside algorithms that provide detailed and meaningful health insights. We didn't want to make just another health tracker, but to provide a lifeline for the millions of people living with epilepsy around the world."
Key features of EpiMonitor include:
Fully medical-grade technology consisting of a wearable and app
Automatic generalized tonic-clonic seizure detection and alerts to caregivers (98% accuracy; low False Alarm Rate)
Ability for users to send self-triggered alerts to caregivers
Up to 7 days of battery life
A user-friendly mobile app with a detailed, automated diary
Daily sleep and activity tracking through Empatica's algorithms
Detailed reports that can be exported and shared with a doctor
High accessibility with app translations in 8 languages
Compatibility with iOS and Android smartphones
Empatica has been the market leader in providing the world's only medical watches for people living with epilepsy for nearly a decade. Epilepsy affects 6 million people in Europe, with approximately 15% of those being children. Studies indicate that up to 40% of epilepsy cases are difficult to treat, and a third of people with epilepsy are refractory to current medications. Sudden Unexpected Death in Epilepsy (SUDEP) is the number one cause of epilepsy-related deaths in people with pharmacoresistant epilepsy. Most SUDEP deaths occur when a generalized tonic-clonic seizure occurs during sleep.
EpiMonitor can be purchased directly from the Empatica website. To learn more visit empatica.com/epimonitor.
Empatica Inc is a pioneer in continuous, unobtrusive remote health monitoring driven by AI. Empatica's platform and technology are used by thousands of institutional partners for research purposes, in studies examining stress, sleep, epilepsy, migraine, depression, addiction, and other conditions. In 2018, Empatica's Embrace wearable received FDA clearance for seizure monitoring, making it the world's first epilepsy watch to be cleared by the FDA. Its successor, EpiMonitor, launched in the US in 2024 after receiving FDA clearance. Empatica's flagship medical wearable, EmbracePlus, has been developed with key partners including HHS, USAMRDC, and NASA.
View source version on businesswire.com: https://www.businesswire.com/news/home/20250414434006/en/
Contacts
Marianna Xenophontospress@empatica.com
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Turkish teams rival Sunderland's interest in Lyon's Georges Mikautadze
Turkish teams rival Sunderland's interest in Lyon's Georges Mikautadze

Yahoo

timean hour ago

  • Yahoo

Turkish teams rival Sunderland's interest in Lyon's Georges Mikautadze

Sunderland are interested in Olympique Lyonnais forward Georges Mikautadze (24), however, they aren't the only club in the race, as Foot Mercato have revealed. Whilst there will not be a fire sale at Lyon following the DNCG's confirmation of the club's relegation to Ligue 2, pending appeal, sales are seen as a necessity, regardless. Be it in Ligue 1 or in Ligue 2, there will be a new period of austerity under new president Michelle Kang. Advertisement Lyon set €20m price tag for Mikautadze? Mikautadze is one of the most sought-after players in this OL squad. Recently promoted Sunderland are interested in the Georgia international, as are AS Roma. However, Foot Mercato understands that two Turkish clubs, Galatasaray and Fenerbahçe, are desperate to sign the striker. Their interest is very strong, whilst clubs from Saudi Arabia are also in the race. As per La Gazzetta dello Sport, OL want €20m for the player, who was brought in from FC Metz last summer for a fee of €18.5m. GFFN | Luke Entwistle

Undiscovered Gems in Europe with Strong Fundamentals July 2025
Undiscovered Gems in Europe with Strong Fundamentals July 2025

Yahoo

timean hour ago

  • Yahoo

Undiscovered Gems in Europe with Strong Fundamentals July 2025

As the pan-European STOXX Europe 600 Index remains relatively stable, with mixed performances across major markets like France's CAC 40 and Germany's DAX, investors are closely watching economic indicators such as eurozone inflation reaching the ECB's target and a steady labor market. In this environment of cautious optimism, identifying stocks with strong fundamentals becomes crucial for navigating potential opportunities amidst broader market sentiment. In light of these conditions, stocks that exhibit robust financial health and resilience to economic fluctuations stand out as promising candidates for consideration. Name Debt To Equity Revenue Growth Earnings Growth Health Rating La Forestière Equatoriale NA -65.30% 37.55% ★★★★★★ Linc NA 101.28% 29.81% ★★★★★★ Caisse Regionale de Credit Agricole Mutuel Toulouse 31 19.46% 0.47% 7.14% ★★★★★☆ Decora 18.47% 11.59% 10.86% ★★★★★☆ Alantra Partners 3.79% -3.99% -23.83% ★★★★★☆ Flügger group 30.11% 1.55% -29.23% ★★★★☆☆ Practic 5.21% 4.49% 7.23% ★★★★☆☆ Inversiones Doalca SOCIMI 15.57% 6.53% 7.16% ★★★★☆☆ Eurofins-Cerep 0.46% 6.80% 6.93% ★★★★☆☆ MCH Group 124.09% 12.40% 43.58% ★★★★☆☆ Click here to see the full list of 324 stocks from our European Undiscovered Gems With Strong Fundamentals screener. We'll examine a selection from our screener results. Simply Wall St Value Rating: ★★★★★★ Overview: Sonaecom SGPS operates globally in the technology, media, and telecommunications sectors with a market capitalization of €764.42 million. Operations: Sonaecom generates revenue primarily from its media segment (€16.38 million) and technology sector (€3.02 million). The company's financial structure reflects a focus on these areas, with holding activities contributing €0.74 million to the overall revenue. Sonaecom, SGPS, a nimble player in the telecom sector, has shown a robust earnings growth of 150% over the past year, outpacing the industry average of 16.8%. Despite a notable one-off loss of €19.3M impacting recent results, its debt-free status provides financial flexibility. With a price-to-earnings ratio at 10.6x compared to the Portuguese market's 11.8x, it seems attractively valued. Recent earnings showed sales at €1.66M and revenue at €4.15M for Q1 2025; however, net income dipped to €13.66M from last year's €25.48M, indicating potential challenges ahead despite its promising growth trajectory. Click here to discover the nuances of Sonaecom SGPS with our detailed analytical health report. Gain insights into Sonaecom SGPS' historical performance by reviewing our past performance report. Simply Wall St Value Rating: ★★★★★★ Overview: engcon AB (publ) specializes in the design, production, and sale of excavator tools across various international markets, with a market cap of approximately SEK14.07 billion. Operations: The company generates revenue primarily from the Construction Machinery & Equipment segment, amounting to SEK1.70 billion. It operates across multiple international markets, focusing on excavator tools. Engcon, a dynamic player in the machinery sector, has seen its earnings soar by 21.5% over the past year, outpacing industry growth of 2.8%. Its debt to equity ratio impressively fell from 15.9% to just 4% over five years, underscoring financial prudence. With EBIT covering interest payments 12.9 times over and high-quality earnings reported, Engcon's financial health seems robust. Recent dividends of SEK 1 per share highlight shareholder value focus while sales rose to SEK 446 million in Q1 from SEK 394 million last year, reflecting solid operational performance amidst strategic market expansions and ongoing patent litigation resolution efforts. Engcon's revenue growth is driven by Nordic market recovery and strategic expansion. Click here to explore the full narrative on Engcon's investment potential. Simply Wall St Value Rating: ★★★★★☆ Overview: Cicor Technologies Ltd. is a global company that, along with its subsidiaries, focuses on the development and manufacturing of electronic components, devices, and systems, with a market capitalization of CHF 729.42 million. Operations: Cicor Technologies generates revenue primarily from its Electronic Manufacturing Services (EMS) Division, which accounts for CHF 438.01 million, and the Advanced Substrates (AS) Division contributing CHF 45.31 million. Cicor Technologies is carving a niche in the European aerospace and defense sectors, leveraging strategic acquisitions like Mercury's electronics site in Geneva. With a satisfactory net debt to equity ratio of 32.2%, the company has seen its earnings grow by 131.7% over the last year, outpacing industry averages. Cicor's price-to-earnings ratio of 26.8x remains competitive within its sector, while EBIT covers interest payments tenfold, showcasing financial robustness. Despite recent shareholder dilution and market volatility, Cicor's strategic moves position it well for future growth amidst geopolitical shifts and currency fluctuations impacting operations across Europe. Cicor Technologies' strategic M&A and operational improvements enhance EBITDA margins significantly. Click here to explore the full narrative on Cicor Technologies. Gain an insight into the universe of 324 European Undiscovered Gems With Strong Fundamentals by clicking here. Got skin in the game with these stocks? Elevate how you manage them by using Simply Wall St's portfolio, where intuitive tools await to help optimize your investment outcomes. Take control of your financial future using Simply Wall St, offering free, in-depth knowledge of international markets to every investor. Explore high-performing small cap companies that haven't yet garnered significant analyst attention. Fuel your portfolio with companies showing strong growth potential, backed by optimistic outlooks both from analysts and management. Find companies with promising cash flow potential yet trading below their fair value. This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Companies discussed in this article include ENXTLS:SNC OM:ENGCON B and SWX:CICN. Have feedback on this article? Concerned about the content? with us directly. Alternatively, email editorial-team@

The New Mercedes CLA Is Actually Selling Great
The New Mercedes CLA Is Actually Selling Great

Motor 1

timean hour ago

  • Motor 1

The New Mercedes CLA Is Actually Selling Great

The Internet hasn't exactly been kind to the new CLA, but the World Wide Web isn't paying Mercedes to keep the lights on. Buyers are, using their hard-earned money. The three-pointed star is happy to report that demand for its electric sedan is strong, with production chief Joerg Burzer describing the order intake as 'very encouraging.' So much so that the compact luxury car will enter a three-shift production schedule later this year to keep up with the high, albeit unspecified, number of orders. Mercedes has been taking orders since April in Germany, but some domestic buyers might have to wait until 2026 for delivery, according to the business newspaper Automobilwoche . Long delivery times are usually a sign of strong demand, unless there are bottlenecks in the production process. There had been some issues with securing rare earths, but Burzer says those problems have been resolved and there are currently no restrictions. Photo by: Mercedes-Benz CLA production is still in the ramp-up phase, with plans to add a gasoline version near the end of the year. It'll be a mild-hybrid model featuring a turbocharged 1.5-liter gasoline engine and an eight-speed dual-clutch automatic transmission. The ICE version should significantly lower the starting price compared to the base electric model. In Germany, the cheapest EV configuration starts at €55,858 for the CLA 250+ with EQ Technology. Demand should grow even further with the launch of a new CLA Shooting Brake . Mercedes is doing another compact wagon, and this time, it'll also be sold as an EV. It will also be assembled at the German plant in Rastatt, where the next-generation GLA crossover is expected to be built as well. Burzer didn't rule out extending the life cycle of the A-Class and B-Class. The two model lines built at the same factory remain popular despite their age. However, replacements for the A-Class hatchback and sedan, along with the B-Class minivan, are not planned, effectively making the CLA the new entry-level model. Another boxy GLB is on the way with gasoline and electric versions, plus a so-called 'Little G' slated for later this decade. 2026 Mercedes CLA 75 Source: Mercedes-Benz Catch Up With Mercedes: '10 Years Too Early:' Mercedes Says Futuristic EQS Styling Is Hurting Sales Mercedes-AMG Admits The Four-Cylinder Hybrid 'Failed to Resonate' With Buyers: Report Source: Automobilwoche Share this Story Facebook X LinkedIn Flipboard Reddit WhatsApp E-Mail Got a tip for us? Email: tips@ Join the conversation ( )

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store